The group fears patients with faulty implants will not receive proper compensation for premature failure, according to the report.
The fear stems from a report associating metal-on-metal implants with high revision surgery rates and an elevated risk of tissue damage due to metal shavings from the implant, the report says.
“The US Drug Watchdog is calling the U.S. metal on metal hip implant fiasco the largest medical device failure in U.S. history involving 500,000 U.S. citizens, and they are convinced there are hundreds of thousands of U.S. citizens who are recipients of a metal-on-metal hip implant that has failed, or will fail prematurely,” reads the group’s website.
More Articles on Supply Chain:
Medical Device Recalls Increased 97% Over Past 10 Years
4 Strategies to Enhance Supply Chain Efficiency
FDA Approves Otezla for Psoriatic Arthritis Treatment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
